Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–19 of 19 trials
Active filters
Clinical trials found
Published and searchable clinical trials
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
- Locations
-
- Universitätsklinik Innsbruck Innsbruck, Austria
- Cliniques Universitaires St. Luc Brussels, Belgium
- UZ Gent Ghent, Belgium
- Jessa ziekenhuis Hasselt, Belgium
NCT06023862
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +29 more
- Locations
-
- Monash Medical Centre Clayton, Clayton Rd., Australia
- Calvary Mater Newcastle Waratah, Edith Saint, Australia
- Peter MacCallum Cancer Centre Melbourne, Grattan Saint, Australia
- University of Hong Kong Hong Kong, Pok Fu Ram
NCT07072234
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +6 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT05500391
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Aggressive Fibromatosis of Abdominal Wall (Disorder), +33 more
- Locations
-
- CHU Amiens Amiens, France
- Centre François Baclesse Caen, France
- Centre Oscar Lambret Lille, France
NCT04623502
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +29 more
- Locations
-
- University of Texas Southwestern Medical Center Dallas, Texas, United States
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
NCT07718854
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +20 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States
NCT01625351
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +60 more
- Locations
-
- St. Jude Children's Research Hospital Memphis, Tennessee, United States
NCT04458597
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +30 more
- Locations
-
- London Regional Cancer Program London, Ontario, Canada
NCT03241745
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +25 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
NCT04227522
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +23 more
- Locations
-
- Universitätsklinikum Aachen Aachen, Germany
- ANregiomed Frauenklinik Ansbach Ansbach, Germany
- Helios Klinikum Berlin-Buch Berlin, Germany
- Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum Berlin, Germany
NCT00563784
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Bronchial Neoplasms, +17 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Ovarian Clear Cell Adenocarcinoma Review
NCT02129036
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +19 more
- Locations
-
Not specified
NCT01824615
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +19 more
- Locations
-
- Cathay General Hospital Taipei, Taiwan
NCT00455975
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +15 more
- Locations
-
- Florida Cancer Specialists Fort Myers, Florida, United States
- Northeast Georgia Medical Center Gainesville, Georgia, United States
- Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States
- Center for Cancer and Blood Disorders Bethesda, Maryland, United States
Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma
NCT01582204
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Carcinoma, +14 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
NCT03355976
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +28 more
- Locations
-
- University of Illinois Chicago Chicago, Illinois, United States
- Rhode Island Hospital Providence, Rhode Island, United States
- Women & Infants Hospital Providence, Rhode Island, United States
- The Miriam Hospital Providence, Rhode Island, United States
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
NCT05544929
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
- Locations
-
- Massachusetts General Hospital . Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- NYU School of Medicine New York, United States
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
NCT00565851
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenocarcinoma, Mucinous, +51 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies
NCT05032040
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +34 more
- Locations
-
- Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
- UCSD Moores Cancer Center La Jolla, California, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- UCLA Medical Center Los Angeles, California, United States